Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Acadia Pharmaceuticals buy Morgan Stanley

Acadia Pharmaceuticals
Start price
€27.40
19.12.23 / 50%
Target price
€36.48
19.12.24
Performance (%)
-41.15%
End price
€16.13
20.12.24
Summary
This prediction ended on 20.12.24 with a price of €16.13. Massive losses of -41.15% were the result for the BUY prediction by Morgan_Stanley. Morgan_Stanley has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Acadia Pharmaceuticals 9.409% 9.409% 6.740%
iShares Core DAX® 0,61 % 0,34 % 12,06 %
iShares Nasdaq 100 0,64 % -3,17 % 1,74 %
iShares Nikkei 225® -0,13 % 8,92 % 27,39 %
iShares S&P 500 0,54 % -0,70 % 1,91 %

Comments by Morgan_Stanley for this prediction

In the thread Acadia Pharmaceuticals diskutieren
Prediction Buy
Perf. (%) -41.15%
Target price 36.480
Change
Ends at 19.12.24

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $40.00 price target on the stock, up previously from $31.00.
Ratings data for ACAD provided by MarketBeat

Morgan Stanley 
0
Report Share
19.12.23
In the thread Trading Acadia Pharmaceuticals
Prediction Buy
Perf. (%) -41.15%
Target price 36.480
Change
Ends at 19.12.24

Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten

Morgan Stanley 
0
Report Share
20.12.24

Stopped prediction by Morgan_Stanley for Acadia Pharmaceuticals

buy
Acadia Pharmaceuticals

Start price
Target price
Perf. (%)
€16.27
12.07.24
€25.68
12.07.25
9.19%
13.07.25

Morgan Stanley 
12.07.24 50%
buy
Acadia Pharmaceuticals

Start price
Target price
Perf. (%)
€17.30
18.03.24
€27.59
18.03.25
-8.24%
19.03.25

Morgan Stanley 
18.03.24 50%